Organization
Hospira, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Hospira, Inc.
... favor of Lilly in the case of Eli Lilly and Company v. Hospira, Inc., denying Hospira's motion for summary judgement and granting Lilly's cross-motion for ...
... the latest in a string of supply chain mishaps for naloxone manufacturer Hospira and its parent company, drug giant Pfizer. “In the event that impacted ...
... drive speed." (Boston Business Journal) INDICATIONS Naloxone recall another black eye for Hospira. My colleague Erika Fry penned a must-read feature for our Fortune 500 ...
... -- The opioid overdose antidote Naloxone has been recalled by its maker, Hospira, the US Food and Drug Administration said Monday. The recall was prompted ...
... -making them. Wall Street cheered when Pfizer announced its intention to buy Hospira, the world's leading maker of generic sterile injectable drugs, for $17 billion, ...
... access program" possible.) Even a generic injectable form of naloxone made by Hospira, purchased by drug giant Pfizer in 2015, more than tripled, from about ...
... Genzyme (Sanofi) Gilead Sciences GlaxoSmithKline (GSK) Greenstone (Pfizer) Grupo Sanborns Grupo Uriach Hospira (Pfizer) IDEV Technologies (Abbott) Ilsung Pharmaceuticals Imperial Credit Private Limited InnoPharma Inc ...
... Amphastar nearly doubled from 2009 to 2016, while a 10-dose amount from Hospira increased from $62 in 2012 to $142 over a four-year period, according ...
... States)Covidien Plc (Ireland)DEMO S.A. (Greece)Fresenius Kabi AG (Germany)Hormel Health Labs, Inc. (United States)Hospira Inc (United States)Halyard Health Inc. (United States)ICU Medical, Inc. (United States)Koninklijke Frieslandcampina ...
... Analysis: Synribo" report has been added to ResearchAndMarkets.com's offering. Synribo (omacetaxine mepesuccinate; Teva/Hospira) is a subcutaneously formulated, semisynthetic form of homoharringtonine, a naturally occurring alkaloid. ...
Subscribe now for full coverage on Hospira, Inc.
Start My Free Trial